Passion and purpose in biotech: Marília Aires' #BIGIMPACT story

Marília Aires, Legal Counsel and Data Protection Officer at Lifebit.png

Earlier this year, we launched our #BIGIMPACT campaign to encourage people with digital and data-driven skills to consider a career in the biotech industry! The #BIGIMPACT website highlights the work of data-driven life sciences and biotech companies, researchers, and entrepreneurs who are developing new drugs, diagnostics, and technologies to improve human health.

In this interview, Marília Aires, Legal Counsel and Data Protection Officer at Lifebit, shares her personal experiences working in the sector, detailing her inspirations and what she is most proud of.


What inspired you to get into the biotech industry?

My goal has always been to contribute to society in a meaningful way and pave the way for a brighter tomorrow for generations to come. I am passionate about making a positive impact, promoting justice, and supporting those in need. Despite my initial inclination towards law, I discovered that my values align very well with biotech, and I got to make my grandmother proud. I firmly believe that any role in this industry can make a difference, including legal and compliance positions. You don't need to be a medical professional or a bioinformatician to have an impact in biotechnology.

What do you enjoy most about the work you do?

As a lawyer, I find the most fulfilling aspect of my work is the opportunity to push myself beyond my limits and learn something new every day. Working with people from diverse backgrounds and cultures has opened my eyes to new perspectives and ways of thinking. The fast-paced nature of the legal industry and biotech keeps me on my toes and constantly challenges me to improve and grow.

Despite the pressure and challenges that come with being part of a legal team, I take pride in my ability to think outside the box and find creative solutions to complex problems. I am grateful for the opportunities that my career has provided me with so far, and I look forward to continuing to learn, grow, and make a positive impact on people's lives.

What are you most proud of in your career so far?

I’m most proud of receiving a Leadership Award for continuous improvement and stepping out of my comfort zone.

How would you describe your company culture?

Lifebit has a meaningful vision of impacting the world by making data available to cure diseases. Our industry is dynamic and moves at a rapid pace, necessitating proactive, efficient, and forward-thinking approaches to work.

What piece of advice would you give your younger self?

If I could go back in time and speak to my younger self, I would offer the sage advice to pursue her passions relentlessly. With unwavering determination and perseverance, she can accomplish even the most improbable feats. So, I would urge her to never lose sight of her aspirations, and to never surrender in the face of adversity. By doing so, she will unlock a world of unforeseen triumphs and accomplishments.

What one word would you use to summarise your experience so far within this industry?

Rewarding! The industry allows people to make a difference and contribute to important causes.

 

More news and updates

SiSaf’s bio-courier technology enables clinical trial success for topical treatment of mild to moderate Alopecia areata

SiSaf Ltd announced that a licensee of the ProSilic® variant of its technology has reported positive topline results from a randomised, placebo-controlled, multi-dose Phase II trial evaluating its topical treatment for mild to moderate (patchy) alopecia areata.

Manchester Met opens applications for September cohort of degree apprenticeships in science and sustainability

Employers looking for new talent or to upskill their current workforce can benefit from degree apprenticeships, starting Autumn 2024.

Discovery Park partners with Canterbury Christ Church University to open CoLab

Discovery Park, Kent’s thriving life science community, has opened the doors to CoLab, a new shared lab facility. In partnership with Canterbury Christ Church University, CoLab has been specially designed for early-stage life science businesses, providing flexible bench space in a collaborative coworking environment.

New blood test could prevent sudden child deaths caused by hereditary heart condition

A new blood test that could identify children with a potentially fatal heart condition has been developed by researchers at UCL (University College London) and Great Ormond Street Hospital (GOSH), thanks to investment from the charity Action Medical Research and self-funded not-for-profit, LifeArc.

CEO Update - 10 June 2024

UK General Election and what it might mean for the industry, including Labour's pledges on Brexit and business taxes. Upcoming events including the Cambridge Wide Open Day and the Life Science Leadership Summit. UK tech companies pitching at the London Stock Exchange and Amber Therapeutics securing $100 million in funding.

Macomics announces appointment of Simon Dew as new Chief Business Officer

Macomics Ltd, a leader in macrophage drug discovery has announced the appointment of Simon Dew in the newly created position of Chief Business Officer (CBO). He will be instrumental in advancing Macomics’ mission to develop first-in-class medicines targeting macrophage-driven diseases of high unmet medical need, in oncology and chronic inflammatory diseases.

 

More within